- BioCryst Pharmaceuticals (NASDAQ:BCRX) commences an $80M public offering of common stock. Price, volume and terms have yet to be announced. Net proceeds will be used for general corporate purposes.
BioCryst Pharma on deck for $80M equity offering
Recommended For You
About BCRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BCRX | - | - |
| BioCryst Pharmaceuticals, Inc. | ||